Nebivolol: new indication. Heart failure: 'me-too' available in single dose strength only. Select better-assessed betablockers.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001578:Benzopyrans / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004983:Ethanolamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D002227:Carbazoles; D004983:Ethanolamines